Calithera surges on arginase deal with Incyte

Calithera Biosciences Inc. (NASDAQ:CALA) jumped $2.15 (47%) to $6.75 on Monday after granting Incyte Corp. (NASDAQ:INCY) worldwide rights

Read the full 181 word article

User Sign In